RE
NTUS

RBC Europe’s Natus Medical Inc NTUS Stock Holding History

RBC Europe’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-425
Closed -$14.3K – 1187
2018
Q1 		$14.3K Hold
425
– – ﹤0.01% 741
2017
Q4 		$16.2K Hold
425
– – ﹤0.01% 736
2017
Q3 		$15.9K Buy
+425
New +$15K ﹤0.01% 732

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

RBC Europe's NTUS Position: Q2 2018 in Review

RBC Europe sold out of Natus Medical Inc (NTUS) in Q2 2018, closing a stake of 425 shares — an estimated $14.3K sold.

RBC Europe first reported a position in NTUS in Q3 2017 and held it in 3 quarters. The position peaked at $16.2K in Q4 2017. 175 funds tracked by Wall St. Rank hold NTUS as of Q2 2018.

  • RBC Europe reported no remaining Natus Medical Inc position as of Q2 2018 after selling out during the quarter.
  • RBC Europe sold 425 Natus Medical Inc shares in Q2 2018, an estimated $14.3K.
  • RBC Europe first reported a position in Natus Medical Inc in Q3 2017 and held it in 3 quarters.
  • RBC Europe's Natus Medical Inc position peaked at $16.2K in Q4 2017.
  • 175 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2018.

Based on RBC Europe's 13F filing for Q2 2018, filed 9 Nov 2023.